{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:28:30Z","timestamp":1791106110833,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Huntington disease (HD) is an adult onset neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin (htt) protein. Htt function is essential for embryonic survival as well as normal function during the postnatal period. In addition to having roles in transcription and transport, recent evidence demonstrates that wild-type htt is neuroprotective <jats:italic>in vivo<\/jats:italic>. To determine whether treatment with wild-type htt would be beneficial in HD, we crossed the YAC128 mouse model of HD with mice that over-express wild-type htt (YAC18 mice) to generate YAC128 mice that over-express wild-type htt (YAC18\/128 mice).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>YAC18\/128 mice were found to express mutant htt at the same level as YAC128 mice and wild-type htt at the same level as YAC18 mice. YAC18\/128 mice show no significant behavioural improvement compared to YAC128 mice in the rotarod test of motor coordination or in an automated open field test. In the brain, YAC18\/128 mice show no significant improvement in striatal volume, striatal neuronal numbers or striatal DARPP-32 expression compared to YAC128 mice. In contrast, striatal neuronal cross-sectional area showed significant improvement in YAC18\/128 mice compared to YAC128 mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>While the over-expression of wild-type htt results in a mild improvement in striatal neuropathology in YAC128 mice, our findings suggest that treatment with wild-type htt may not be sufficient to ameliorate the symptoms of HD in this model.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2202-7-80","type":"journal-article","created":{"date-parts":[[2006,12,5]],"date-time":"2006-12-05T19:18:46Z","timestamp":1165346326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease"],"prefix":"10.1186","volume":"7","author":[{"given":"Jeremy M","family":"Van Raamsdonk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,5]]},"reference":[{"key":"285_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, et al: A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 1999, 23: 181-192. 10.1016\/S0896-6273(00)80764-3.","journal-title":"Neuron"},{"key":"285_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/2510","volume":"20","author":"PH Reddy","year":"1998","unstructured":"Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell WO, et al: Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet. 1998, 20: 198-202. 10.1038\/2510.","journal-title":"Nat Genet"},{"key":"285_CR3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, et al: Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003, 12: 1555-1567. 10.1093\/hmg\/ddg169.","journal-title":"Hum Mol Genet"},{"key":"285_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S: Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci. 2001, 24: 182-188. 10.1016\/S0166-2236(00)01721-5.","journal-title":"Trends Neurosci"},{"key":"285_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","volume":"14","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Bissada N, Vogl AW, Hayden MR, et al: Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum Mol Genet. 2005, 14: 1379-1392. 10.1093\/hmg\/ddi147.","journal-title":"Hum Mol Genet"},{"key":"285_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, et al: Inactivation of the mouse Huntington's disease gene homolog Hdh. Science. 1995, 269: 407-410. 10.1126\/science.7618107.","journal-title":"Science"},{"key":"285_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J, et al: Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 1995, 81: 811-823. 10.1016\/0092-8674(95)90542-1.","journal-title":"Cell"},{"key":"285_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A: Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet. 1995, 11: 155-163. 10.1038\/ng1095-155.","journal-title":"Nat Genet"},{"key":"285_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0006-8993(98)01312-2","volume":"818","author":"JR O'Kusky","year":"1999","unstructured":"O'Kusky JR, Nasir J, Cicchetti F, Parent A, Hayden MR: Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene. Brain Res. 1999, 818: 468-479. 10.1016\/S0006-8993(98)01312-2.","journal-title":"Brain Res"},{"key":"285_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, et al: Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet. 1997, 17: 404-410. 10.1038\/ng1297-404.","journal-title":"Nat Genet"},{"key":"285_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis I, Levine MS, Zeitlin S: Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet. 2000, 26: 300-306. 10.1038\/81593.","journal-title":"Nat Genet"},{"key":"285_CR12","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De Fraja C, Conti L, Sipione S, Sciorati C, et al: Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci. 2000, 20: 3705-3713.","journal-title":"J Neurosci"},{"key":"285_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.38.7.450","volume":"38","author":"LW Ho","year":"2001","unstructured":"Ho LW, Brown R, Maxwell M, Wyttenbach A, Rubinsztein DC: Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease. J Med Genet. 2001, 38: 450-452. 10.1136\/jmg.38.7.450.","journal-title":"J Med Genet"},{"key":"285_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1086\/318207","volume":"68","author":"BR Leavitt","year":"2001","unstructured":"Leavitt BR, Guttman JA, Hodgson JG, Kimel GH, Singaraja R, Vogl AW, et al: Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am J Hum Genet. 2001, 68: 313-324. 10.1086\/318207.","journal-title":"Am J Hum Genet"},{"key":"285_CR15","doi-asserted-by":"publisher","first-page":"41299","DOI":"10.1074\/jbc.M008408200","volume":"275","author":"AS Hackam","year":"2000","unstructured":"Hackam AS, Yassa AS, Singaraja R, Metzler M, Gutekunst CA, Gan L, et al: Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem. 2000, 275: 41299-41308. 10.1074\/jbc.M008408200.","journal-title":"J Biol Chem"},{"key":"285_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, et al: Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell. 2004, 118: 127-138. 10.1016\/j.cell.2004.06.018.","journal-title":"Cell"},{"key":"285_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, et al: Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science. 2001, 293: 493-498. 10.1126\/science.1059581.","journal-title":"Science"},{"key":"285_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, et al: Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003, 35: 76-83. 10.1038\/ng1219.","journal-title":"Nat Genet"},{"key":"285_CR19","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","volume":"96","author":"O Hansson","year":"1999","unstructured":"Hansson O, Petersen A, Leist M, Nicotera P, Castilho RF, Brundin P: Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci USA. 1999, 96: 8727-8732. 10.1073\/pnas.96.15.8727.","journal-title":"Proc Natl Acad Sci USA"},{"key":"285_CR20","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","volume":"322","author":"I Bezprozvanny","year":"2004","unstructured":"Bezprozvanny I, Hayden MR: Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun. 2004, 322: 1310-1317. 10.1016\/j.bbrc.2004.08.035.","journal-title":"Biochem Biophys Res Commun"},{"key":"285_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH: Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol. 1999, 45: 25-32. 10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E.","journal-title":"Ann Neurol"},{"key":"285_CR22","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/hmg\/5.12.1875","volume":"5","author":"JG Hodgson","year":"1996","unstructured":"Hodgson JG, Smith DJ, McCutcheon K, Koide HB, Nishiyama K, Dinulos MB, et al: Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum Mol Genet. 1996, 5: 1875-1885. 10.1093\/hmg\/5.12.1875.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"285_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","volume":"96","author":"BR Leavitt","year":"2006","unstructured":"Leavitt BR, van Raamsdonk JM, Shehadeh J, Fernandes HB, Murphy Z, Graham RK, Raymond LA, Hayden MR: Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem . 2006, 96 (4): 1121-9. 10.1111\/j.1471-4159.2005.03605.x.","journal-title":"J Neurochem"},{"key":"285_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ: Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 2004, 20: 146-154. 10.1016\/j.tig.2004.01.008.","journal-title":"Trends Genet"},{"key":"285_CR25","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR: Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci. 2005, 25: 4169-4180. 10.1523\/JNEUROSCI.0590-05.2005.","journal-title":"J Neurosci"},{"key":"285_CR26","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","volume":"15","author":"JM Van Raamsdonk","year":"2006","unstructured":"Van Raamsdonk JM, Gibson WT, Pearson J, Murphy Z, Lu G, Leavitt BR, et al: Body weight is modulated by levels of full-length Huntingtin. Hum Mol Genet. 2006, 15: 1513-1523. 10.1093\/hmg\/ddl072.","journal-title":"Hum Mol Genet"},{"key":"285_CR27","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1074\/jbc.271.32.19385","volume":"271","author":"MA Kalchman","year":"1996","unstructured":"Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, et al: Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem. 1996, 271: 19385-19394. 10.1074\/jbc.271.32.19385.","journal-title":"J Biol Chem"},{"key":"285_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.expneurol.2005.07.021","volume":"196","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Lu G, Barakauskas VE, Barr AM, et al: Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease. Exp Neurol. 2005, 196: 266-272. 10.1016\/j.expneurol.2005.07.021.","journal-title":"Exp Neurol"},{"key":"285_CR29","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, et al: Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci. 2003, 23: 9418-9427.","journal-title":"J Neurosci"},{"key":"285_CR30","doi-asserted-by":"publisher","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","volume":"24","author":"RJ Ferrante","year":"2004","unstructured":"Ferrante RJ, Ryu H, Kubilus JK, D'Mello S, Sugars KL, Lee J, et al: Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J Neurosci. 2004, 24: 10335-10342. 10.1523\/JNEUROSCI.2599-04.2004.","journal-title":"J Neurosci"},{"key":"285_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1074\/jbc.M410210200","volume":"280","author":"G Gardian","year":"2005","unstructured":"Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, et al: Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem. 2005, 280: 556-563.","journal-title":"J Biol Chem"},{"key":"285_CR32","first-page":"172","volume":"36","author":"A Durr","year":"1999","unstructured":"Durr A, Hahn-Barma V, Brice A, Pecheux C, Dode C, Feingold J: Homozygosity in Huntington's disease. J Med Genet. 1999, 36: 172-173.","journal-title":"J Med Genet"},{"key":"285_CR33","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, et al: A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994, 330: 1401-1406. 10.1056\/NEJM199405193302001.","journal-title":"N Engl J Med"},{"key":"285_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1212\/WNL.53.4.801","volume":"53","author":"F Laccone","year":"1999","unstructured":"Laccone F, Engel U, Holinski-Feder E, Weigell-Weber M, Marczinek K, Nolte D, et al: DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland. Neurology. 1999, 53: 801-806.","journal-title":"Neurology"},{"key":"285_CR35","first-page":"615","volume":"45","author":"RH Myers","year":"1989","unstructured":"Myers RH, Leavitt J, Farrer LA, Jagadeesh J, McFarlane H, Mastromauro CA, et al: Homozygote for Huntington disease. Am J Hum Genet. 1989, 45: 615-618.","journal-title":"Am J Hum Genet"},{"key":"285_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, et al: Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain. 2003, 126: 946-955. 10.1093\/brain\/awg077.","journal-title":"Brain"},{"key":"285_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/326194a0","volume":"326","author":"NS Wexler","year":"1987","unstructured":"Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, et al: Homozygotes for Huntington's disease. Nature. 1987, 326: 194-197. 10.1038\/326194a0.","journal-title":"Nature"},{"key":"285_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, et al: Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet. 2001, 10: 137-144. 10.1093\/hmg\/10.2.137.","journal-title":"Hum Mol Genet"},{"key":"285_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","volume":"9","author":"VC Wheeler","year":"2000","unstructured":"Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, Li XJ, et al: Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet. 2000, 9: 503-513. 10.1093\/hmg\/9.4.503.","journal-title":"Hum Mol Genet"},{"key":"285_CR40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.nbd.2005.08.007","volume":"21","author":"RK Graham","year":"2006","unstructured":"Graham RK, Slow EJ, Deng Y, Bissada N, Lu G, Pearson J, et al: Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiol Dis. 2006, 21: 444-455. 10.1016\/j.nbd.2005.08.007.","journal-title":"Neurobiol Dis"},{"key":"285_CR41","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","volume":"10","author":"W Auerbach","year":"2001","unstructured":"Auerbach W, Hurlbert MS, Hilditch-Maguire P, Wadghiri YZ, Wheeler VC, Cohen SI, et al: The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum Mol Genet. 2001, 10: 2515-2523. 10.1093\/hmg\/10.22.2515.","journal-title":"Hum Mol Genet"},{"key":"285_CR42","volume-title":"EMBO J","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Leavitt BR, van Raamsdonk JM, Dragatsis I, Goldowitz D, Macdonald ME, Hayden MR, Friedlander RM: Huntingtin inhibits caspase-3 activation. EMBO J. 2006, [Epub ahead of print]"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-7-80.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:43:06Z","timestamp":1630464186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-7-80"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-7-80","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"9 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"80"}}